Product NDC: | 0378-6260 |
Proprietary Name: | Propranolol Hydrochloride |
Non Proprietary Name: | propranolol hydrochloride |
Active Ingredient(s): | 160 mg/1 & nbsp; propranolol hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-6260 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078022 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120614 |
Package NDC: | 0378-6260-05 |
Package Description: | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-6260-05) |
NDC Code | 0378-6260-05 |
Proprietary Name | Propranolol Hydrochloride |
Package Description | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-6260-05) |
Product NDC | 0378-6260 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | propranolol hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120614 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | PROPRANOLOL HYDROCHLORIDE |
Strength Number | 160 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |